Merck KGaA (FRA: MRK)‘s stock had its “sell” rating reiterated by equities research analysts at AlphaValue in a research note issued to investors on Thursday. They currently have a $113.64 (€88) price target on the stock.

A number of other analysts have also recently weighed in on MRK. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Merck KGaA in a research note to investors on Thursday. They now have a $125.97 price target on the stock. Separately, analysts at Independent Research GmbH reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Wednesday. They now have a $123.68 price target on the stock. Finally, analysts at Commerzbank Corporates & Markets reiterated a “hold” rating on shares of Merck KGaA in a research note to investors on Monday, November 19th. They now have a $120.51 price target on the stock.

Shares of Merck KGaA traded up 3.54% during mid-day trading on Thursday, hitting €106.50. Merck KGaA has a one year low of €72.00 and a one year high of €103.00.

.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.